PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
45%
Total
Publications
417
Total Open
Publications
189
Total
Citations
13K
Open Access
Percentage
45%
Total
Publications
417
Total Open
Publications
189
Total
Citations
13K
Breakdown
Publisher Open
13%
Both
23%
Other Platform Open
7%
Closed
57%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 43%
61
Hybrid 28%
39
No Guarantees 29%
41
Other Platform Open
Domain 84%
109
Other Internet 15%
19
Institution 11%
14
Public 3%
4
Preprint 2%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 110 |
DOI | Other Internet | 18 |
University of Melbourne - Minerva Access | Institution | 4 |
Figshare | Public | 4 |
Research Square | Preprint | 3 |
Europe PMC | Domain | 3 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 2 |
University of Pisa - CINECA IRIS Institutial research information system | Institution | 2 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |